Compound Detail
CHEMBL401114
(+)-HAEMANTHAMINE Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL401114 |
| Name | (+)-HAEMANTHAMINE |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YGPRSGKVLATIHT-HSHDSVGOSA-N |
29
Targets
40
Activities
1
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
301.3
MW (Da)
1.19
ALogP
5
HBA
1
HBD
51.2
PSA (Ų)
0.79
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 40 meas. best 6.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Jurkat CHEMBL397 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| SK-BR-3 CHEMBL613834 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| BT-549 CHEMBL614072 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| PANC-1 CHEMBL614139 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| SW480 CHEMBL612544 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| NCI-H1299 CHEMBL612255 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| COLO 201 CHEMBL4523567 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| AGS CHEMBL613860 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| MOLT-4 CHEMBL614177 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| A549 CHEMBL392 | IC50 | 6.52 | 5.7475 | 300.0 | 4 |
| NHDF CHEMBL614200 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 6.52 | 5.805 | 300.0 | 2 |
| SAOS-2 CHEMBL614894 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| HT-29 CHEMBL384 | IC50 | 6.52 | 6.1 | 300.0 | 2 |
| HL-60 CHEMBL383 | IC50 | 6.52 | 6.185 | 300.0 | 2 |
| A2780 CHEMBL614004 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| HeLa CHEMBL399 | IC50 | 5.89 | 5.525 | 1300.0 | 2 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.89 | 5.89 | 1300.0 | 1 |
| CCRF-CEM CHEMBL382 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
| K562 CHEMBL385 | IC50 | 5.6 | 5.535 | 2500.0 | 2 |
| BJ CHEMBL614358 | IC50 | 5.57 | 5.57 | 2700.0 | 1 |
| G-361 CHEMBL614036 | IC50 | 5.43 | 5.43 | 3700.0 | 1 |
| SK-OV-3 CHEMBL614925 | IC50 | 5.43 | 5.43 | 3700.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 5.32 | 5.32 | 4800.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| B16-F10 CHEMBL612656 | IC50 | 5.17 | 5.17 | 6800.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 5.17 | 5.1467 | 6800.0 | 3 |
| SK-MEL CHEMBL614914 | IC50 | 5.07 | 5.07 | 8500.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 39229678 | 10.1021/acs.jnatprod.4c00825 | ADMET | 6 |
| 20550100 | 10.1021/np9008255 | NON-PROTEIN TARGET | 3 |
| 39229678 | 10.1021/acs.jnatprod.4c00825 | Unchecked | 3 |
| 27218860 | 10.1016/j.ejmech.2016.05.004 | HeLa S3 | 2 |
| 29409754 | 10.1016/j.bmcl.2018.01.041 | Unchecked | 2 |
| 23190013 | 10.1021/np3005425 | K562 | 2 |
| 23190013 | 10.1021/np3005425 | A549 | 2 |
| 32309949 | 10.1021/acs.jnatprod.9b00561 | Cholinesterase | 2 |
| 32309949 | 10.1021/acs.jnatprod.9b00561 | Acetylcholinesterase | 2 |
| 23190013 | 10.1021/np3005425 | HepG2 | 2 |
| 23190013 | 10.1021/np3005425 | HT-29 | 2 |
| 22921081 | 10.1016/j.bmcl.2012.08.005 | Unchecked | 2 |
| 22921081 | 10.1016/j.bmcl.2012.08.005 | MCF7 | 1 |
| 23190013 | 10.1021/np3005425 | Unchecked | 1 |
| 22921081 | 10.1016/j.bmcl.2012.08.005 | CCRF-CEM | 1 |
| 22921081 | 10.1016/j.bmcl.2012.08.005 | K562 | 1 |
| 22921081 | 10.1016/j.bmcl.2012.08.005 | G-361 | 1 |
| 22921081 | 10.1016/j.bmcl.2012.08.005 | BJ | 1 |
| 19299148 | 10.1016/j.bmc.2009.02.050 | Plasmodium falciparum | 1 |
| 20550100 | 10.1021/np9008255 | B16-F10 | 1 |
Data from ChEMBL 36 via Core Engine